Proyecto PESA - Progression of early subclinical atherosclerosis

MICINN, ISCIII, CNIC, Fundación PROCNIC, Santander MICINN ISCIII CNIC Fundación PROCNIC Santander Proyecto PESA - Progression of early subclinical atherosclerosis

Publicaciones

  1. Fernandez-Ortiz A, Jimenez-Borreguero LJ, Penalvo JL, Ordovas JM, Mocoroa A, Fernandez-Friera L, Laclaustra M, Garcia L, Molina J, Mendiguren JM, Lopez-Melgar B, de Vega VM, Alonso-Farto JC, Guallar E, Sillesen H, Rudd JH, Fayad ZA, Ibanez B, Sanz G, Fuster V. The Progression and Early detection of Subclinical Atherosclerosis (PESA) study: Rationale and design. Am Heart J. 2013;166(6):990-8. doi: 10.1016/j.ahj.2013.08.024. PMID: 24268213.
  2. Fernandez-Friera L, Penalvo JL, Fernandez-Ortiz A, Ibanez B, Lopez-Melgar B, Laclaustra M, Oliva B, Mocoroa A, Mendiguren J, Martinez de Vega V, Garcia L, Molina J, Sanchez-Gonzalez J, Guzman G, Alonso-Farto JC, Guallar E, Civeira F, Sillesen H, Pocock S, Ordovas JM, Sanz G, Jimenez-Borreguero LJ, Fuster V. Prevalence, Vascular Distribution and Multi-territorial Extent of Subclinical Atherosclerosis in a Middle-Aged Cohort: The PESA (Progression of Early Subclinical Atherosclerosis) Study. Circulation. 2015;131(24):2104-13. doi: 10.1161/CIRCULATIONAHA.114.014310. PMID: 25882487.

    http://hdl.handle.net/20.500.12105/8352

  3. Fernandez-Alvira JM, Fuster V, Dorado B, Soberon N, Flores I, Gallardo M, Pocock S, Blasco MA, Andres V. Short Telomere Load, Telomere Length, and Subclinical Atherosclerosis: The PESA Study. J Am Coll Cardiol. 2016;67(21):2467-76. doi: 10.1016/j.jacc.2016.03.530. PMID: 27230041.

    http://hdl.handle.net/20.500.12105/5229

  4. Penalvo JL, Fernandez-Friera L, Lopez-Melgar B, Uzhova I, Oliva B, Fernandez-Alvira JM, Laclaustra M, Pocock S, Mocoroa A, Mendiguren JM, Sanz G, Guallar E, Bansilal S, Vedanthan R, Jimenez-Borreguero LJ, Ibanez B, Ordovas JM, Fernandez-Ortiz A, Bueno H, Fuster V. Association Between a Social-Business Eating Pattern and Early Asymptomatic Atherosclerosis. J Am Coll Cardiol. 2016;68(8):805-14. doi: 10.1016/j.jacc.2016.05.080. PMID: 27539172.

    http://hdl.handle.net/20.500.12105/5204

  5. Hurtado-Roca Y, Bueno H, Fernandez-Ortiz A, Ordovas JM, Ibanez B, Fuster V, Rodriguez-Artalejo F, Laclaustra M. Oxidized LDL is Associated with Metabolic Syndrome Traits Independently of Central Obesity and Insulin Resistance. Diabetes. 2017;66(2):474-82. doi: 10.2337/db16-0933. PMID: 27993926.

    http://hdl.handle.net/20.500.12105/8355

  6. Coffeng JK, van der Ploeg HP, Castellano JM, Fernandez-Alvira JM, Ibanez B, Garcia-Lunar I, van der Beek AJ, Fernandez-Ortiz A, Mocoroa A, Garcia-Leal L, Cardenas E, Rojas C, Martinez-Castro MI, Santiago-Sacristan S, Fernandez-Gallardo M, Mendiguren JM, Bansilal S, van Mechelen W, Fuster V. A 30-month worksite-based lifestyle program to promote cardiovascular health in middle-aged bank employees: Design of the TANSNIP-PESA randomized controlled trial. Am Heart J. 2017;184:121-32. doi: 10.1016/j.ahj.2016.11.002. PMID: 28224926.

    http://hdl.handle.net/20.500.12105/5164

  7. Lopez-Melgar B, Fernandez-Friera L, Oliva B, Garcia-Ruiz JM, Penalvo JL, Gomez-Talavera S, Sanchez-Gonzalez J, Mendiguren JM, Ibanez B, Fernandez-Ortiz A, Sanz J, Fuster V. Subclinical Atherosclerosis Burden by 3D Ultrasound in Mid-Life: The PESA Study. J Am Coll Cardiol. 2017;70(3):301-13. doi: 10.1016/j.jacc.2017.05.033. PMID: 28705310.

    http://hdl.handle.net/20.500.12105/8353

  8. Uzhova I, Fuster V, Fernandez-Ortiz A, Ordovas JM, Sanz J, Fernandez-Friera L, Lopez-Melgar B, Mendiguren JM, Ibanez B, Bueno H, Penalvo JL. The Importance of Breakfast in Atherosclerosis Disease: Insights From the PESA Study. J Am Coll Cardiol. 2017;70(15):1833-42. doi: 10.1016/j.jacc.2017.08.027. PMID: 28982495.
  9. Fernandez-Alvira JM, Fuster V, Pocock S, Sanz J, Fernandez-Friera L, Laclaustra M, Fernandez-Jimenez R, Mendiguren J, Fernandez-Ortiz A, Ibanez B, Bueno H. Predicting Subclinical Atherosclerosis in Low-Risk Individuals: Ideal Cardiovascular Health Score and Fuster-BEWAT Score. J Am Coll Cardiol. 2017;70(20):2463-73. doi: 10.1016/j.jacc.2017.09.032. PMID: 29145946.

    http://hdl.handle.net/20.500.12105/6493

  10. Fernandez-Friera L, Fuster V, Lopez-Melgar B, Oliva B, Garcia-Ruiz JM, Mendiguren J, Bueno H, Pocock S, Ibanez B, Fernandez-Ortiz A, Sanz J. Normal LDL-Cholesterol Levels Are Associated With Subclinical Atherosclerosis in the Absence of Risk Factors. J Am Coll Cardiol. 2017;70(24):2979-91. doi: 10.1016/j.jacc.2017.10.024. PMID: 29241485.

    http://hdl.handle.net/20.500.12105/7211

  11. Dominguez F, Fuster V, Fernandez-Alvira JM, Fernandez-Friera L, Lopez-Melgar B, Blanco-Rojo R, Fernandez-Ortiz A, Garcia-Pavia P, Sanz J, Mendiguren JM, Ibanez B, Bueno H, Lara-Pezzi E, Ordovas JM. Association of Sleep Duration and Quality With Subclinical Atherosclerosis. J Am Coll Cardiol. 2019;73(2):134-44. doi: 10.1016/j.jacc.2018.10.060. PMID: 30654884.

    http://hdl.handle.net/20.500.12105/7988

  12. Tsilingiri K, de la Fuente H, Relano M, Sanchez-Diaz R, Rodriguez C, Crespo J, Sanchez-Cabo F, Dopazo A, Alonso-Lebrero JL, Vara A, Vazquez J, Casasnovas JM, Alfonso F, Ibanez B, Fuster V, Martinez-Gonzalez J, Martin P, Sanchez-Madrid F. oxLDL Receptor in Lymphocytes Prevents Atherosclerosis and Predicts Subclinical Disease. Circulation. 2019;139(2):243-55. doi: 10.1161/circulationaha.118.034326. PMID: 30586697.

    http://hdl.handle.net/20.500.12105/7016

  13. Fernandez-Friera L, Fuster V, Lopez-Melgar B, Oliva B, Sanchez-Gonzalez J, Macias A, Perez-Asenjo B, Zamudio D, Alonso-Farto JC, Espana S, Mendiguren J, Bueno H, Garcia-Ruiz JM, Ibanez B, Fernandez-Ortiz A, Sanz J. Vascular Inflammation in Subclinical Atherosclerosis Detected by Hybrid PET/MRI. J Am Coll Cardiol. 2019;73(12):1371-82. doi: 10.1016/j.jacc.2018.12.075. PMID: 30922468.

    http://hdl.handle.net/20.500.12105/8351

  14. Redondo-Bravo L, Fernandez-Alvira JM, Gorriz J, Mendiguren JM, Sanz J, Fernandez-Friera L, Garcia-Ruiz JM, Fernandez-Ortiz A, Ibanez B, Bueno H, Fuster V. Does Socioeconomic Status Influence the Risk of Subclinical Atherosclerosis?: A Mediation Model. J Am Coll Cardiol. 2019;74(4):526-35. doi: 10.1016/j.jacc.2019.05.042. PMID: 31345427.

    http://hdl.handle.net/20.500.12105/8348

  15. 15. Yin X, Willinger CM, Keefe J, Liu J, Fernández-Ortiz A, Ibáñez B, Peñalvo J, Adourian A, Chen G, Corella D, Pamplona R, Portero-Otin M, Jove M, Courchesne P, van Duijn CM, Fuster V, Ordovás JM, Demirkan A, Larson MG, Levy D. EBioMedicine. 2019 Dec 23;51:102520. doi: 10.1016/j.ebiom.2019.10.046.
2014 © PESA CNIC-Santander. Todos los derechos reservados.